OptiBiotix Health Plc (AIM:OPTI)
London · Delayed Price · Currency is GBP · Price in GBX 5.88
+0.03 (0.43%)
Sep 25, 2026, 4:02 PM GMT
OptiBiotix Health Financials Overview
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1.29 | 1.17 | 0.87 | 0.64 | 0.46 | 2.21 |
Revenue Growth | 10.46% | 34.02% | 35.09% | 40.92% | -79.35% | 45.28% |
Gross Profit Gross Profit Growth | 0.69 | 0.61 | 0.33 | 0.32 | 0.24 | 1.12 |
Operating Income Operating Income Growth | -2.45 | -3.13 | -2.27 | -1.7 | -2.49 | -1.37 |
Net Income Net Income Growth | -4.29 | -3.89 | -1.81 | -2.04 | 2.59 | 6.26 |
Earnings Per Share EPS Growth | -0.04 | -0.04 | -0.02 | -0.02 | 0.03 | 0.07 |
EPS Growth | - | - | - | - | -57.56% | 7.91% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
China China Growth | 0.05 | 0.07 | 0.13 | 0.08 | - | - |
India India Growth | 0.05 | 0.16 | 0.17 | - | 0.06 | - |
Rest of World Rest of World Growth | 0.46 | 0.27 | 0.1 | 0.15 | 0.16 | 0.74 |
Unites States of America Unites States of America Growth | 0.31 | 0.35 | 0.14 | 0.2 | 0.1 | 0.83 |
United Kingdom United Kingdom Growth | - | 0.32 | 0.33 | 0.22 | 0.14 | 0.65 |
Total Total Growth | 1.29 | 1.17 | 0.87 | 0.64 | 0.46 | 2.21 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 0.99 | 1.04 | 0.74 | 0.64 | 1.05 | 2.01 |
Total Debt Total Debt Growth | - | - | - | - | - | 0.82 |
Net Cash (Debt) Net Cash Growth | 0.99 | 1.04 | 0.74 | 0.64 | 1.05 | 1.19 |
Net Cash Growth | -4.63% | 40.33% | 16.38% | -39.64% | -11.45% | 1178.51% |
Net Cash Per Share Net Cash Per Share Growth | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -1.71 | -1.77 | -1.77 | -1.53 | -1.11 | -1.57 |
Capital Expenditures CapEx Growth | - | - | - | - | - | - |
Free Cash Flow Free Cash Flow Growth | -1.71 | -1.77 | -1.77 | -1.53 | -1.11 | -1.57 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 53.65% | 52.66% | 38.05% | 49.69% | 53.39% | 50.75% |
Operating Margin | -190.06% | -268.61% | -260.46% | -263.35% | -544.64% | -61.68% |
Pretax Margin | -338.35% | -338.16% | -214.48% | -317.24% | 534.14% | 279.12% |
Profit Margin | -332.69% | -333.62% | -207.47% | -316.62% | 566.08% | 282.92% |
FCF Margin | -132.69% | -151.80% | -203.22% | -237.11% | -242.67% | -70.72% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 4.67 | 6.46 |
Forward PE | - | 25.95 | 25.95 | 25.95 | 25.95 | - |
PS Ratio | 4.69 | 5.98 | 20.26 | 37.88 | 26.44 | 18.28 |